In breast cancers, DOT1L forms a transcriptionally active complex with c-Myc and p300 to facilitate H3K79 methylation and acetylation in the promoter regions of EMT-TFs and enhance their de-repression, consequently promoting EMT-induced CSC properties (Cho et al., 2015). Here, DOT1L is linked to breast carcinoma.